BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
ZBTB7A
,
Coagulation
,
Lung cancer
,
Retina
,
Personalized medicine
,
Cisplatin
,
rs7903146
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dopamine antagonist
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?
Rationale in support of the use of selective dopamine D₃ receptor antagonists for the pharmacotherap…
Synergistic effects of dopamine D2-like receptor antagonist sulpiride and β-blocker propranolol on l…
Dopamine antagonists and brief vision distinguish lens-induced- and form-deprivation-induced myopia.
Discovery of antagonists of tick dopamine receptors via chemical library screening and comparative p…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Dopamine D-2 Antagonist Use in Poor Responders in IVF: a Randomized Controlled Trial
Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity
Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either W…
Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti…
Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ